Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Rhea-AI Summary
Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, announced its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference from February 14 to 16, 2023. Founded in 2014, Prenetics aims to decentralize healthcare by making consumer health, clinical care, and medical genomics accessible worldwide. The company operates in nine locations, including the UK, Hong Kong, and India, and offers services such as genetic testing, colorectal cancer screening, and COVID-19 testing. The event underscores Prenetics' commitment to innovation in health and diagnostics.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, PRE declined 2.64%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
LONDON and HONG KONG, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, today announced that its management team will participate virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference from February 14 to February 16, 2023.
About Prenetics
Founded in 2014, Prenetics is a major global diagnostic and genetic testing company with the mission to bring health closer to millions of people globally and decentralize healthcare by making the three pillars — Consumer Health, Clinical Care and Medical & Cancer Genomics — comprehensive and accessible to anyone, at anytime and anywhere. Prenetics is led by visionary entrepreneur, Danny Yeung, with operations across nine locations, including The United Kingdom, Hong Kong, India, South Africa, and Southeast Asia. Prenetics develops consumer genetic testing and early colorectal cancer screening and provides COVID-19 testing, rapid point of care and at-home diagnostic testing and medical genetic testing. Prenetics is listed on NASDAQ with the ticker PRE. To learn more about Prenetics, visit www.prenetics.com.
| Investor Relations Contact: | ||
| investors@prenetics.com | ||
| ICR Westwicke: | ||
| Caroline Corner | +415 202 5678 | Email: caroline.corner@westwicke.com |
| Media contact: | ||
| Strategic Public Relations Group | ||
| Corinne Ho | +852 2114 4911 | Email: corinne.ho@sprg.com.hk |
FAQ
When will Prenetics participate in the BTIG MedTech Conference?
What is the ticker symbol for Prenetics?
What services does Prenetics provide?
Where does Prenetics operate?
What is the mission of Prenetics?
